The virological response to highly active antiretroviral therapy over the first 24 weeks of therapy according to the pre-therapy viral load and the weeks 4-8 viral load

AIDS

Volumn 15, Issue 1, 2001, Pages 47-54

  Lepri, Alessandro Cozzi ^a   Miller, Veronica ^b   Phillips, Andrew N ^a   Rabenau, Holger ^b   Sabin, Caroline A ^a   Staszewski, Schlomo ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Adherence; Antiretroviral naive; Drug absorption; Resistance; Viral suppression; Weeks 4 8 viral load

Indexed keywords

ABACAVIR; AMPRENAVIR; ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; CALCULATION; DATA BASE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; PROBABILITY; TREATMENT FAILURE; TREATMENT OUTCOME; VIRUS LOAD;

ADULT; AGED; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE INHIBITORS; TIME FACTORS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 0035808547     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200101050-00008     Document Type: Article

References (15)

1. Virological response to protease inhibitor therapy in a HIV clinic cohort
2. Predictors of viral response and subsequent virological treatment failure in patients with HIV starting a protease inhibitor
3. Predictors of long-term response to protease inhibitor therapy in a cohort of HIV-infected patients
4. Predictors of optimal virological response to potent antiretroviral therapy
5. CD4 cell count at the third month of HAART may predict clinical failure
6. Ordered accumulation of mutations in HIV protease confers resistance to ritonavir
7. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors
8. Patterns of plasma HIV RNA responses in antiretroviral treatment success and failure
9. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: A prospective cohort study
10. HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: Response to both initial and salvage therapy
11. Virological response to a second-line protease inhibitor (PI) regimen: Laboratory markers and choice of treatment
12. Antiretroviral therapy in adults. Updated recommendations of the International AIDS Society - USA Panel
13. Characterizing patterns of drug-taking behaviour with a multiple drug regimen in an AIDS clinical trial
14. Adherence to antiretroviral and pneumocystis prophylaxis in AIDS disease
15. Effect of plasma drug concentrations on HIV-1 clearance rate in antiretroviral naive patients during quadruple drug combination therapy